跳至主要内容
临床试验/IRCT2016020421745N4
IRCT2016020421745N4已完成2 期

Clinical trial of comparing the effects of Escitalopram with Setraline on the severity of signs and symptoms of patients with obsessive compulsive disorder

Vice chancellor of research Shiraz University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients with obsessive compulsive disorder (OCD) that diagnosed with interview by psychiatrist according to DSM-IV TR; Yale-Brown-obsessive-compulsive scale equal or more than 18; Informed consent of patients.
  • Exclusion criteria: Other psychiatric disorder diagnosis according to axis I and II; Major medical illness like hypertension, diabetes, cardiovascular disease, renal disease and gastrointestinal disease; Pregnancy and lactation; Substance or alcohol abuse; Any intolerable adverse side effects of treatment; Any SSRI usage in past 5 weeks; Patients younger than 18 years and older than 65 years old.

排除标准

  • 未提供

研究者

发起方
Vice chancellor of research Shiraz University of Medical Sciences

相似试验